20172020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 3122 Cancers

International and National Collaboration Publications and projects within past five years.

Publications

Comparison of clinically relevant oncolytic virus platforms for enhancing T-cell therapy of solid tumors

Cervera-Carrascon, V., Quixabeira, D. C. A., Havunen, R., Santos, J. M., Kutvonen, E., Clubb, J. H. A., Siurala, M., Heiniö, C., Zafar, S., Koivula, T., Lumen, D., Vaha, M., Garcia-Horsman, A., Airaksinen, A. J., Sorsa, S., Anttila, M., Hukkanen, V., Kanerva, A. & Hemminki, A., 26 Jun 2020, In : Molecular Therapy - Oncolytics. 17, p. 47-60 14 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity

Santos, J. M., Heiniö, C., Cervera-Carrascon, V., Quixabeira, D. C. A., Siurala, M., Havunen, R., Butzow, R., Zafar, S., de Gruijl, T., Lassus, H., Kanerva, A. & Hemminki, A., Jan 2020, In : Journal for Immunotherapy of Cancer. 8, 1, 15 p., e000188.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition

Cervera-Carrascon, V., Quixabeira, D. C. A., Santos, J. M., Havunen, R., Zafar, S., Hemminki, O., Heiniö, C., Munaro, E., Siurala, M., Sorsa, S., Mirtti, T., Järvinen, P., Mildh, M., Nisen, H., Rannikko, A., Anttila, M., Kanerva, A. & Hemminki, A., 2020, In : OncoImmunology. 9, 1, 12 p., e1761229.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Effect of Genetic Modifications on Physical and Functional Titers of Adenoviral Cancer Gene Therapy Constructs

Heiniö, C., Sorsa, S., Siurala, M., Grönberg-Vähä-Koskela, S., Havunen, R., Haavisto, E., Koski, A., Hemminki, O., Zafar, S., Cervera-Carrascon, V., Munaro, E., Kanerva, A. & Hemminki, A., 1 Jun 2019, In : Human Gene Therapy. 30, 6, p. 740-752 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy

Santos, J. M., Cervera-Carrascon, V., Havunen, R., Zafar, S., Siurala, M., Sorsa, S., Anttila, M., Kanerva, A. & Hemminki, A., 5 Sep 2018, In : Molecular therapy. 26, 9, p. 2243-2254 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File